viewFrontier IP Group PLC

Frontier IP ups stake in AI logistics firm Celerum

Celerum is a spin-out from Robert Gordon University in Aberdeen to commercialise the work of professor John McCall, the head of its computing, science and digital media school

Frontier IP Group PLC - Frontier IP ups stake in AI logistics firm Celerum

Frontier IP Group PLC (LON:FIPP) has increased its stake in artificial intelligence (AI) firm Celerum Limited to 33.8% from 10%.

The IP investment group said it had acquired the increased stake in return for an investment of £25,000 as well as converting a previous loan of £21,818 into equity and providing £50,000 worth of strategic, business and hands-on software development services.

READ: Frontier IP’s Exscientia begins clinical trial for world’s first AI-created drug

Celerum, which was spun out from Robert Gordon University in Aberdeen, is developing an AI to help businesses improve the operational efficiency of their logistics and supply chains.

"We are delighted to increase our equity stake in Celerum. The Company's artificial intelligence has already proved its worth with industry, and clearly has enormous potential to improve efficiency within the transport services and logistics sector, and benefit many other industries", said Frontier chief executive Neil Crabb.

Quick facts: Frontier IP Group PLC

Price: 54.5 GBX

Market: AIM
Market Cap: £27.62 m

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events


The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of Frontier IP Group PLC named herein, including the promotion by the Company of Frontier IP Group PLC in any Content on the Site, the Company...



Frontier IP's The Vaccine Group to begin animal coronavirus vaccine trials...

Frontier IP Group PLC's (LON:FIPP) Neil Crabb tells Proactive London's  Andrew Scott its portfolio company The Vaccine Group is to 'imminently' start trials of its coronavirus vaccine in animals. Crabb says the idea is to develop an animal inoculation that would prevent the spread of...

1 week, 5 days ago

2 min read